Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Mercury General Corporation is an insurance-property & casualty business based in the US. Mercury General Corporation shares (MCY) are listed on the NYSE and all prices are listed in US Dollars. Mercury General Corporation employs 4,300 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Latest market close | $44.30 |
|---|---|
| 52-week range | $43.33 - $62.91 |
| 50-day moving average | $48.98 |
| 200-day moving average | $52.89 |
| Wall St. target price | $65.00 |
| PE ratio | N/A |
| Dividend yield | $2.535 (5.77%) |
| Earnings per share (TTM) | $-1.01 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $44.3 from 2022-06-30
| 1 week (2022-06-23) | 0.66% |
|---|---|
| 1 month (2022-06-01) | -8.87% |
| 3 months (2022-03-28) | N/A |
| 6 months (2021-12-31) | -16.51% |
| 1 year (2021-07-01) | -32.57% |
|---|---|
| 2 years (2020-07-01) | 10.89% |
| 3 years (2019-07-01) | 63.33 |
| 5 years (2017-06-30) | 54 |
Valuing Mercury General Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Mercury General Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Mercury General Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.19. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Mercury General Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Mercury General Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $14.5 million.
The EBITDA is a measure of a Mercury General Corporation's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $3.8 billion |
|---|---|
| Gross profit TTM | $649.9 million |
| Return on assets TTM | -0.65% |
| Return on equity TTM | -2.79% |
| Profit margin | -1.47% |
| Book value | $34.46 |
| Market capitalisation | $2.4 billion |
TTM: trailing 12 months
Dividend payout ratio: 3.3% of net profits
Recently Mercury General Corporation has paid out, on average, around 3.3% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 5.77% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Mercury General Corporation shareholders could enjoy a 5.77% return on their shares, in the form of dividend payments. In Mercury General Corporation's case, that would currently equate to about $2.535 per share.
While Mercury General Corporation's payout ratio might seem low, this can signify that Mercury General Corporation is investing more in its future growth.
Mercury General Corporation's most recent dividend payout was on 29 June 2022. The latest dividend was paid out to all shareholders who bought their shares by 14 June 2022 (the "ex-dividend date").
Mercury General Corporation's shares were split on a 2:1 basis on 9 October 1997. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Mercury General Corporation shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Mercury General Corporation shares which in turn could have impacted Mercury General Corporation's share price.
Over the last 12 months, Mercury General Corporation's shares have ranged in value from as little as $43.33 up to $62.9131. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Mercury General Corporation's is 0.4387. This would suggest that Mercury General Corporation's shares are less volatile than average (for this exchange).
Mercury General Corporation, together with its subsidiaries, engages in writing personal automobile insurance in the United States. The company also writes homeowners, commercial automobile, commercial property, mechanical protection, and umbrella insurance products. Its automobile insurance products include collision, property damage, bodily injury, comprehensive, personal injury protection, underinsured and uninsured motorist, and other hazards; and homeowners insurance products comprise dwelling, liability, personal property, fire, and other hazards. The company sells its policies through a network of independent agents and insurance agencies, as well as directly through internet sales portals in Arizona, California, Florida, Georgia, Illinois, Nevada, New Jersey, New York, Oklahoma, Texas, and Virginia. Mercury General Corporation was founded in 1961 and is headquartered in Los Angeles, California. .
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Everything we know about the Warrantee IPO, plus information on how to buy in.
Everything we know about the Treasure Global IPO, plus information on how to buy in.
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.